WANBURY

March 24 (Reuters) - Wanbury Ltd WANB.NS:

• WANBURY LTD - LAUNCHES CORIMINIC CPM DROPS FOR PEDIATRIC USE

• WANBURY LTD - LAUNCHES CORIMINIC NS NASAL DROPS FOR CHILDREN

Source text: ID:nNSELc6Vx

Further company coverage: WANB.NS

((Reuters.Briefs@thomsonreuters.com;))

March 12 (Reuters) - Wanbury Ltd WANB.NS:

• RECEIVES SERTRALINE FORM II APPROVAL FROM ANVISA, BRAZIL

• RECEIVES APPROVAL FOR SPECIAL GRADE METFORMIN

Source text: ID:nBSE3w4BB

Further company coverage: WANB.NS

((Reuters.Briefs@thomsonreuters.com;))

Jan 28 (Reuters) - Wanbury Ltd WANB.NS:

• WANBURY LTD - LAUNCHES COMMERCIAL PRODUCTION OF ANAESTHETIC API

• WANBURY LTD - NEW API TO GENERATE 180 MILLION RUPEES IN Q4 FY 2025-26

Source text: ID:nNSEbPzctS

Further company coverage: WANB.NS

((Reuters.Briefs@thomsonreuters.com;))

** Wanbury's shares WANB.NS rise 9%, set for fifth straight session of gains

** Pharma co to launch two new products for formulation, including iron tablets and Ketamine

** Over 255,000 shares traded, 1.6x WANB's 30-day avg

** Stock has surged ~41% in March vs a ~10% rise in Nifty pharma index .NIPHARM

(Reporting by Ashna Teresa Britto in Bengaluru)

((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))

Feb 12 (Reuters) - Wanbury Ltd WANB.NS:

• WANBURY LTD - TO ISSUE NCDS UP TO 2 BILLION RUPEES

Source text: ID:nBSE6vRkTp

Further company coverage: WANB.NS

((Reuters.Briefs@thomsonreuters.com;))

Jan 3 (Reuters) - Wanbury Ltd WANB.NS:

• WANBURY - COMPLETES ANVISA AUDIT AT TANUKU PLANT

• WANBURY - FULL-FLEDGED MANUFACTURING OPERATIONS STARTED AT TANUKU PLANT

Source text: ID:nBSEbxM8RV

Further company coverage: WANB.NS

((reuters.briefs@thomsonreuters.com;))

Dec 20 (Reuters) - Wanbury Ltd WANB.NS:

• TANUKU PLANT COMPLETES ANVISA INSPECTION

• INSPECTION COMPLETED WITH ZERO OBSERVATIONS FOR 5 APIS

Source text: ID:nBSE1W24Ym

Further company coverage: WANB.NS

((Reuters.Briefs@thomsonreuters.com;;))

** Shares of Wanbury WANB.NS rise 4.45% to 218.49 rupees

** Pharma co gets establishment inspection report (EIR) from U.S. FDA for its Maharashtra facility

** Inspection classified as "no action indicated" with "zero Form-483 observations"

** Zero Form-483 observations indicate the facility is in acceptable state of compliance with current good manufacturing practices

** Stock up about 17% this week, on course for best weekly performance since September 2023 - NSE data

(Reporting by Bharath Rajeswaran in Bengaluru)

((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))

** Shares of Wanbury Ltd WANB.NS rise as much as 5%, before trimming gains to trade 4.2% higher

** Pharma co said United States Food and Drug Administration completed inspection at co's Patalganga site in Maharashtra with zero observations

** Stock set for best one-day rise in a month

** Stock set to rise for a fifth straight quarter, gaining nearly 4x in the last four quarters

** Trading vol is 1.5x the 30-day daily avg

** Stock up ~31% in 2024 so far, after gaining 2.5x in 2023

(Reporting by Anuran Sadhu in Bengaluru)

((Anuran.Sadhu@thomsonreuters.com ;))

May 16 (Reuters) - Wanbury Ltd WANB.NS:

• WANBURY LTD MARCH-QUARTER CONSOL PAT 336.3 MILLION RUPEES VERSUS 10.2 MILLION RUPEES

• WANBURY LTD MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 1.39 BILLION RUPEES VERSUS 1.33 BILLION RUPEES

Source text for Eikon: ID:nNSEzHxMk

Further company coverage: WANB.NS

((Reuters.Briefs@thomsonreuters.com;;))

Oct 20 (Reuters) - Wanbury Ltd WANB.NS:

• INDIA'S WANBURY LTD SEPT-QUARTER CONSOL PAT 73.6 MILLION RUPEES VERSUS LOSS 8.9 MILLION RUPEES YEAR AGO

• WANBURY LTD SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 1.44 BILLION RUPEES VERSUS 1.24 BILLION RUPEES YEAR AGO

• WANBURY LTD - APPROVED ISSUE OF CONVERTIBLE WARRANTS WORTH UPTO 240 MILLION RUPEES

Source text for Eikon: [ID:]

Further company coverage: WANB.NS

((Reuters.Briefs@thomsonreuters.com;))

Oct 17 (Reuters) - Wanbury Ltd WANB.NS:

• TO CONSIDER RAISING OF FUNDS

Source text for Eikon: ID:nBSEbV0Sf3

Further company coverage: WANB.NS

((Reuters.Briefs@thomsonreuters.com;))

Aug 11 (Reuters) - Wanbury Ltd WANB.NS:

• INDIA'S WANBURY JUNE-QUARTER CONSOL PAT 46.9 MILLION RUPEES VERSUS LOSS 72.4 MILLION RUPEES

• WANBURY JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 1.46 BILLION RUPEES VERSUS 1.17 BILLION RUPEES

Source text for Eikon: ID:nBSE9qKvsj

Further company coverage: WANB.NS

((Reuters.Briefs@thomsonreuters.com;;))

July 6 (Reuters) - Wanbury Ltd WANB.NS:

• TO CONSIDER ISSUE OF NONCONVERTIBLE DEBENTURES ON PRIVATE PLACEMENT BASIS

Source text for Eikon: ID:nBSE3Kv3vR

Further company coverage: WANB.NS

((Reuters.Briefs@thomsonreuters.com;))